Study of Anlotinib in Patients With Differentiated Thyroid Cancer(ALTER01032)
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Clinical Trials Related to Anlotinib
Related studies linked through entity extraction aliases.
Study of Anlotinib in Patients With Gastric Cancer(ALTER0503)
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Study of Anlotinib in Patients With Soft Tissue Sarcoma（STS）(ALTER0203)
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（ALTER0303）
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Study of Anlotinib in Patients With Metastatic Colorectal Cancer（mCRC）(ALTER0703)
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Phase II Study of Anlotinib in Patients With Advanced Renal Cell Carcinoma That Have Failed Or Are Intolerant To TKIs Therapy
- Status
- UNKNOWN
- Phase
- PHASE2
Phase II Study of Anlotinib Versus Sunitinib in Patients With Advanced Renal Cell Carcinoma（RCC）
- Status
- UNKNOWN
- Phase
- PHASE2
To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in the Phase II/III Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Phase II Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（ALTER0302）
- Status
- COMPLETED
- Phase
- PHASE2
A Phase II Study of Anlotinib in STS Patients
- Status
- COMPLETED
- Phase
- PHASE2
A Phase II Study of Anlotinib in MTC Patients
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I Study of Anlotinib on Tolerance and Pharmacokinetics
- Status
- COMPLETED
- Phase
- PHASE1